Shares of WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY – Get Free Report) saw strong trading volume on Thursday. Approximately 7,941 shares changed hands during trading, an increase of 60% from the previous session’s volume of 4,972 shares. The stock last traded at $24.28 and had previously closed at $25.12.
Analyst Ratings Changes
Separately, Zacks Research lowered WuXi AppTec from a “strong-buy” rating to a “hold” rating in a report on Monday, October 5th. One research analyst has rated the stock with a Buy rating and one has given a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy”.
Check Out Our Latest Research Report on WuXi AppTec
WuXi AppTec Stock Down 4.8%
The stock’s 50 day simple moving average is $25.79 and its 200 day simple moving average is $20.76.
About WuXi AppTec
WuXi AppTec is a global pharmaceutical and biotechnology services company that provides contract research, development and manufacturing services. The company supports drug developers throughout the product life cycle, from early-stage discovery and laboratory testing through clinical development and commercial production.
Its offerings include medicinal and synthetic chemistry, biology research, preclinical and clinical testing, regulatory support, pharmaceutical manufacturing, and the development and manufacturing of advanced therapies.
See Also
- Five stocks we like better than WuXi AppTec
- Flywire’s Rapid Growth Faces a Q3 Test—Is Its Stock Already Too Expensive?
- Cologuard Is Working—So Why Isn’t Abbott Stock?
- Micron’s Taiwan Strike: A High-Stakes Fight Over AI Profits
- Intuitive Surgical Stock: Margin Hit Masks Strong Q3 Growth Story
Receive News & Ratings for WuXi AppTec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi AppTec and related companies with MarketBeat.com's FREE daily email newsletter.
